TTK Healthcare Limited
TTK Healthcare Limited (TTKHLTCARE) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Diversified›Diversified›Diversified›Diversified
ttkhealthcare.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-02
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
|---|---|---|---|---|
| Sales | 190 Cr | 226 Cr | 204 Cr | 209 Cr |
| Operating expenses (approx.) | 178 Cr | 224 Cr | 198 Cr | 202 Cr |
| EBITDA | 12 Cr | 3 Cr | 5 Cr | 7 Cr |
| OPM % | 6.3% | 1.2% | 2.6% | 3.4% |
| Other income | 19 Cr | 18 Cr | 19 Cr | 17 Cr |
| Interest | 0.90 Cr | 0.77 Cr | 0.84 Cr | 0.68 Cr |
| Depreciation | 2 Cr | 2 Cr | 2 Cr | 2 Cr |
| Profit before tax | 22 Cr | 18 Cr | 21 Cr | 14 Cr |
| Tax % | 25.8% | 26.4% | 4.3% | 25.2% |
| Net profit | 16 Cr | 13 Cr | 20 Cr | 11 Cr |
| EPS (₹) | ₹11.43 | ₹9.20 | ₹14.43 | ₹7.45 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2025 | TTM |
|---|---|---|
| Sales | 801 Cr | Sign in for TTM |
| Operating expenses (approx.) | 767 Cr | Sign in for TTM |
| EBITDA | 35 Cr | Sign in for TTM |
| OPM % | 4.3% | Sign in for TTM |
| Other income | 71 Cr | Sign in for TTM |
| Interest | 3 Cr | Sign in for TTM |
| Depreciation | 8 Cr | Sign in for TTM |
| Profit before tax | 108 Cr | Sign in for TTM |
| Tax % | 24.6% | Sign in for TTM |
| Net profit | 82 Cr | Sign in for TTM |
| EPS (₹) | ₹57.79 | Sign in for TTM |
| Dividend payout % | 17.3% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 |
|---|---|
| Equity capital | 14 Cr |
| Reserves | 1,051 Cr |
| Borrowings | 24 Cr |
| Other liabilities | 192 Cr |
| Total liabilities | 1,281 Cr |
| Fixed assets (net) | 81 Cr |
| CWIP | 0.08 Cr |
| Investments | 11 Cr |
| Inventories | 109 Cr |
| Trade receivables | 91 Cr |
| Cash & bank | 9 Cr |
| Other assets | 981 Cr |
| Total assets | 1,281 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2025 |
|---|---|
| Cash from operating activity | -4 Cr |
| Cash from investing | 20 Cr |
| Cash from financing | -18 Cr |
| Net cash flow | -2 Cr |
| Free cash flow (OCF − Capex) | -17 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2025 |
|---|---|
| ROCE % | 10.3% |
| ROE % | 7.7% |
| Debtor days | 41 |
| Inventory days | 202 |
| Days payable | 199 |
| Cash conversion cycle | 44 |
| Debt / equity | 0.02 |
| Current ratio | 5.23 |
| Net debt / EBITDA | 0.44 |
Compare with peers
Loading peers…